Anteilseigner
AVIC Trust Co., Ltd. (5,74 %) OrbiMed Advisors Private Equity (4,83 %) Dimensional Fund Advisors LP (0,39 %) E Fund Management Co., Ltd. (0,33 %) The Vanguard Group, Inc. (0,19 %) Dimensional Fund Advisors Ltd. (0,08 %) Vanguard Global Advisers LLC (0,07 %) State Street Global Advisors Ltd. (0,05 %) Bosera Asset Management Co., Ltd. (0,04 %) Vanguard Investments Australia Ltd. (0,01 %) BlackRock Asset Management North Asia Ltd. (0,01 %) DFA Australia Ltd. (0,00 %)
Kontakt
Shenzhen Hepalink Pharmaceutical Co. Ltd.